Paid Clinical Trials Cedar Rapids
Discover 485 paid clinical trials in Cedar Rapids, Iowa. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
BNT327, Chemotherapy, Investigational AgentsSafety, Effectiveness, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Sponsor:
BioNTech SE
Location:
Code:
NCT06712316
Conditions
Non-small Cell Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
BNT327
Pembrolizumab
Carboplatin
Pemetrexed
Paclitaxel
Genetic StudiesMolecular Genetics Studies of Cancer Patients and Their Relatives
Sponsor:
City of Hope Medical Center
Location:
Code:
NCT04185935
Conditions
Malignant Neoplasm
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Accepted
Interventions
Biospecimen Collection
Questionnaire Administration
GM1 with PaclitaxelFinding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II)
Sponsor:
Alliance for Clinical Trials in Oncology
Location:
Code:
NCT05751668
Conditions
Anatomic Stage IV Breast Cancer AJCC v8
Chemotherapy-Induced Peripheral Neuropathy
Metastatic Breast Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Paclitaxel
Monosialotetrahexosylganglioside
Questionnaire Administration
Quality-of-life assessment
Placebo Administration
BNT327 & ChemotherapySafety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy
Sponsor:
BioNTech SE
Location:
Code:
NCT06449222
Conditions
Locally Advanced Breast Cancer
Triple Negative Breast Cancer
Metastatic Triple Negative Breast Cancers
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
BNT327 Dose Level 1 (DL1)
BNT327 Dose Level 1 (DL2)
Nab-placlitaxel
Carboplatin
Gemcitabine
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Focused Radiation & Systemic TherapyFocused Radiation Versus Systemic Therapy for Kidney Cancer Patients With Limited Metastasis, SOAR Study
Sponsor:
ECOG-ACRIN Cancer Research Group
Location:
Code:
NCT05863351
Conditions
Metastatic Renal Cell Carcinoma
Stage IV Renal Cell Cancer AJCC v8
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Computed Tomography
Magnetic Resonance Imaging
Questionnaire Administration
Stereotactic Ablative Radiotherapy
Systemic Therapy
Targeted TherapyTargeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT05564377
Conditions
Advanced Malignant Solid Neoplasm
Anatomic Stage III Breast Cancer AJCC v8
Anatomic Stage IV Breast Cancer AJCC v8
Locally Advanced Malignant Solid Neoplasm
Malignant Female Reproductive System Neoplasm
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
Alpelisib
Binimetinib
Biopsy Procedure
Biospecimen Collection
Bone Marrow Aspiration
Observational StudyEvaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors
Sponsor:
ECOG-ACRIN Cancer Research Group
Location:
Code:
NCT06002828
Conditions
Hodgkin Lymphoma
Non-Hodgkin Lymphoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Quality-of-Life Assessment
Questionnaire Administration
Regional RadiotherapyRegional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
Sponsor:
Canadian Cancer Trials Group
Location:
Code:
NCT03488693
Conditions
Breast Cancer
Eligibility Criteria
Sex: Female
Age: 35+
Healthy Volunteers: Not accepted
Interventions
Radiation
No Radiation
Daratumumab, Bortezomib, Lenalidomide, DexamethasoneTesting the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Sponsor:
ECOG-ACRIN Cancer Research Group
Location:
Code:
NCT04566328
Conditions
Plasma Cell Myeloma
RISS Stage I Plasma Cell Myeloma
RISS Stage II Plasma Cell Myeloma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Bortezomib
Daratumumab and Hyaluronidase-fihj
Dexamethasone
Lenalidomide
Quality-of-Life Assessment